BioSyngen
A clinical stage biotech developing first-in-class cell therapies targeting solid and liquid tumors.
20 employees · est. 2016 · Singapore
Innovent Biologics
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people
846 employees · est. 2011 · Suzhou, China
Innovent Biologics is the older company (2016 vs 2011); Innovent Biologics is the larger of the two.
Side-by-Side Comparison
| Metric | BioSyngen | Innovent Biologics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2011 older |
| Headquarters | ||
| Headquarters | Singapore | Suzhou, China |
| Employees | ||
| Employees | 20 | 846 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Manufacturing |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $500.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Cell Therapy, Cancer Treatment, Clinical Trials, Immunotherapy, GMP Manufacturing, Solid Tumors, Lymphoproliferative Diseases, Translational Medicine, R&D, Global Headquarters, Collaborations, Venture Capital, Singapore, Guangzhou | Biopharmaceuticals, Monoclonal Antibodies, Biosimilars, Drug Development, Cancer Treatment, Metabolic Diseases, Autoimmune Diseases, Biologics Manufacturing, Clinical Trials, Commercialization, R&D, Global Standard Compliance, Funding, Strategic Partnerships, International Market Expansion |
| Website | ||
| Website | biosyngen.com | innoventbio.com |
About BioSyngen
BioSyngen is a Singapore-based biotechnology startup founded in 2016 with a clear focus on developing first-in-class cell therapies targeting solid and liquid tumors. The company has made significant strides in its clinical stage, with its first-in-class products entering Phase I/II clinical trials...
About Innovent Biologics
Innovent Biologics is a biopharmaceutical company established in 2011 with a commitment to develop and commercialize high-quality innovative medicines. The company focuses on treating major diseases such as cancer. It was publicly listed on the Main Board of the Stock Exchange of Hong Kong Limited w...
We will tell you when either one moves
BounceWatch watches BioSyngen and Innovent Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioSyngen and Innovent Biologics — by email.
Frequently Asked Questions
Compare BioSyngen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BioSyngen on 12 Sep 2024, and Innovent Biologics on 20 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
